| Molecular Interaction Atlas (MIA) |
|
| Indication(s) of ETHISTERONE |
| Disease Entry |
ICD 11 |
Status |
REF |
| Discovery agent |
N.A.
|
Investigative |
[2] |
|
|
|
ETHISTERONE Interacts with 1 DTT Molecule(s)
| DTT Name |
DTT ID |
UniProt ID |
Mode of Action |
REF |
|
Tyrosinase (TYR)
|
TTULVH8
|
TYRO_HUMAN
|
Inhibitor
|
[2] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
ETHISTERONE Interacts with 2 DOT Molecule(s)
| DOT Name |
DOT ID |
UniProt ID |
Mode of Action |
REF |
|
Myb-related protein A (MYBL1)
|
OTBJMC2P
|
MYBA_HUMAN
|
Increases Expression
|
[5] |
|
Protein GREB1 (GREB1)
|
OTU6ZA26
|
GREB1_HUMAN
|
Increases Expression
|
[5] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
| Indication(s) of Diethylcarbamazine |
| Disease Entry |
ICD 11 |
Status |
REF |
| Elephantiasis |
N.A.
|
Approved |
[3] |
| Loiasis |
N.A.
|
Approved |
[3] |
| Lymphatic filariasis |
1F66.3
|
Approved |
[4] |
| Onchocerciasis |
1F6A
|
Approved |
[3] |
|
|
|
Diethylcarbamazine Interacts with 1 DTT Molecule(s)
| DTT Name |
DTT ID |
UniProt ID |
Mode of Action |
REF |
|
Arachidonate 5-lipoxygenase (5-LOX)
|
TT2J34L
|
LOX5_HUMAN
|
Inhibitor
|
[6] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
Diethylcarbamazine Interacts with 1 DOT Molecule(s)
| DOT Name |
DOT ID |
UniProt ID |
Mode of Action |
REF |
|
Cytochrome P450 2C19 (CYP2C19)
|
OTFMJYYE
|
CP2CJ_HUMAN
|
Increases Activity
|
[7] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
|
|
|
|
|
|